1 / 15

Outline

yitta
Download Presentation

Outline

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Progress achieved and outstanding issues on the way to adopting an International Regime on Access and Benefit Sharing under the Convention on Biological DiversityPresented to theWorkshop on Access and Benefit Sharing in Non-commercial ResearchLyle GlowkaLegal AdvisorConvention on Biological Diversity

  2. Outline • CBD ABS provisions • Progress and trends over the last 15 years • International Regime on ABS • Suggestions on making this meeting count

  3. CBD Provisions Three objectives: • Conservation of biological diversity • Sustainable use of its components • Fair and equitable sharing of the benefits from use of genetic resources

  4. CBD Innovation “New” Equity Relationship: Access to genetic resources in exchange for sharing of benefits derived from their use

  5. Provisions of the CBD Four fundamental access-related principles: • Sovereign rights over genetic resources • Facilitate access to genetic resources • Prior informed consent • Mutually agreed terms

  6. Provisions of the CBD Five fundamental benefit-sharing obligations: • Research and development results (article 15(7)) • Commercial or other benefits derived from use (article 15(7)) • Access to and transfer of technology using genetic resources (article 16(3)) • Participation in biotechnological research on the genetic resources (article 19(1)) • Priority access to results and benefits arising from biotechnological use (article 19(2))

  7. Over the last 15 years… • Near universal CBD membership • Global level processes • [FAO: Commission on Genetic Resources (On-going)] • WTO: TRIPS Agreement (1995) • CBD: WG-Art. 8(j) (1998) • ATS: Bioprospecting in Antarctica (1999) • WIPO: Intergovernmental Committee on Intellectual Property and Genetic Resources, Traditional Knowledge and Folklore (2001) • FAO: International Treaty on PGRFA (Rome, 2001) • UNGA: UNICPOLOS (2001) and Ad Hoc Working Group on Biodiversity Beyond the Limits of Any National Jurisdiction (2004) • WSSD: International Regime on ABS (2002) • UN: Declaration on the Rights of Indigenous Peoples (2007) • Other processes • Regional initiatives • National initiatives • Sectoral initiatives (e.g., codes of conduct) • Capacity building projects • Countless publications and studies • Actual bioprospecting deals

  8. Over the last 15 years… • At national and regional level:Primary focus has been the provider side of ABS • +/- 60 countries: have actually established an ABS regime or are working towards one • 12 of 17 “like-minded mega-diverse countries” have created an ABS regime • At global level:Primary focus is compliance and enforcement

  9. Progress on Benefit SharingSource: CBD Technical Series 38 (Laird and Wynberg, 2008) • Benefit sharing: Growing as standard [business] practice • Major CBD acheivement: Standards of best practice have emerged • Need for PIC and benefit sharing is understood (e.g., Larger or more socially responsible organisations) • Sectors still out of the loop • Questions remain: Who should benefit? • Businesses prefer to direct benefits to scientific research institutions and partners (rather than governments) • ILCs should benefit but challenges remain • Lack of resolution: What are appropriate benefits? • Scale of benefits difficult to resolve • Need to take a wider perspective: Importance of non-monetary benefits • Importance of partnerships • Access to local expertise • Legal certainty • +/- Compliance mechanism

  10. ABS: Practical ConcernsSource: CBD Technical Series 38 (Laird and Wynberg, 2008) • Misunderstanding and mistrust • Biopiracy charges have increased • Growing concern with negative attacks, bad press and criminalisation • Lack of awareness of ethical and legal obligations • Lack of governmental understanding of commercial/scientific research practices and risks • Lack of competent national authorities (or unclear responsibilities) • Regulatory confusion, complexity and shifting goal posts • Legal certainty concerns • Impacts on science and development

  11. ABS Timeline • CBD: Entry into force (1993) • COP IV:Panel of Experts on ABS(1998) • COP V: Open-ended Working Group on ABS(2000) • COP VI:Bonn Guidelines(2002) • WSSD:Political mandate for international regime on ABS(2002) • COP VII:WG-ABS mandated to work on international regime (2004) • COP VIII:Renewed WG-ABS mandate/established 2010 deadline(2006) • COP IX: Established basis of negotiations to 2010 and identified outstanding issues for further exploration (2008)

  12. The way forward… COP Decision IX/12 on ABS • Main basis for negotiations agreed • WG-ABS (x3 meetings) • WG-ABS7: Objective, scope, compliance, benefit sharing and access • WG-ABS8: Nature, TK associated with GRs, compliance, benefit sharing and access • WG-ABS9: Refinement • Expert groups (x3 meetings) • Concepts / terms / sectoral approaches • Compliance-related issues • TK associated with GR (Art 8(j) WG) • Commissioned studies (x5) • Direct methods to ID genetic resources using DNA sequences • Options to track / monitor genetic resources (“Persistent global unique identifiers”) • Compatibility with other regimes (e.g., FAO Int’l Treaty PGRFA) • Cross-jurisdictional access to justice: Real and transactional costs • Ensuring compliance in conformity with ILC customary laws • Individual experts • Should “economic rent” be charged for access to genetic resources? • Global Information System on PGRFA (FAO Int’l Treaty PGRFA)

  13. Making this meeting count Expert group: Concepts / terms / sectoral approaches (2-5 Dec 2008, Namibia) Questions posed: What are the different ways of understanding biological resources, genetic resources, derivatives and products? What are the implications for the IR’s development including in relation to…commercial and non-commercial research? Identify different forms of GR use in relation to sectoral and sub-sectoral activities in the context of ensuring benefit sharing (CBD Art 15(7)) Identify and describe sector-specific characteristics of ABS arrangements and identify the differences, if any, between approaches in sectors What are the range of options and approaches for taking these different characteristics into account in order to bring coherence to ABS-related practices in different sectors? How this workshop can help: Lend insight on the distinctions between BRs, GRs, derivatives and products, as well as the implications of technological trends, e.g., genomics, proteomics, metagenomics and publically accessible data/databases Clarify the various “communities of biodiversity research” and their existing practices with respect to GR use and ABS to date (NB: CBD applicable to terrestrial and marine realms) Identify options/approaches: Is there a common approach to ABS that could be taken across the broader biodiversity research community or will a range of approaches be needed to address individual biodiversity research communities? +/- Recommendations on simplified access procedures?

  14. Making this meeting count Expert group: Compliance (end of Jan 2009, Japan) Questions posed (x4): What kind of voluntary measures are available to enhance compliance of users of foreign genetic resources? Are particular compliance measures needed for research with non-commercial intent? If so, how could these measures address challenges arising from changes in intent and/or users, particularly considering the challenge arising from a lack of compliance with relevant access and benefit-sharing legislation and/or mutually agreed terms. How this workshop can help: Biodiversity research communities: Are there gaps in defining and applying best practice? Codes of conduct: How to ensure compliance? Suggestions to overcome obstacles? Role of community etiquette, peer pressure, public funding agencies, journals, etc.? Other measures? Perspectives on the role of intermediaries Perspectives on the change of use/intent issue

  15. Outlook COP 10, Nagoya, Japan, October 2010

More Related